首页> 美国卫生研究院文献>BioMed Research International >Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies
【2h】

Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies

机译:使用药理学模型,分子对接和分子动力学模拟研究从中草药中发现醛固酮合酶的潜在抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aldosterone synthase (CYP11B2) is a key enzyme for the biosynthesis of aldosterone, which plays a significant role for the regulation of blood pressure. Excess aldosterone can cause the dysregulation of the renin-angiotensin-aldosterone system (RAAS) and lead to hypertension. Therefore, research and development of CYP11B2 inhibitor are regarded as a novel approach for the treatment of hypertension. In this study, the pharmacophore models of CYP11B2 inhibitors were generated and the optimal model was used to identify potential CYP11B2 inhibitors from the Traditional Chinese Medicine Database (TCMD, Version 2009). The hits were further refined by molecular docking and the interactions between compounds and CYP11B2 were analyzed. Compounds with high Fitvalue, high docking score, and expected interactions with key residues were selected as potential CYP11B2 inhibitors. Two most promising compounds, ethyl caffeate and labiatenic acid, with high Fitvalue and docking score were reserved for molecular dynamics (MD) study. All of them have stability of ligand binding which suggested that they might perform the inhibitory effect on CYP11B2. This study provided candidates for novel drug-like CYP11B2 inhibitors by molecular simulation methods for the hypertension treatment.
机译:醛固酮合酶(CYP11B2)是醛固酮生物合成的关键酶,对调节血压起着重要作用。过量的醛固酮会引起肾素-血管紧张素-醛固酮系统(RAAS)失调并导致高血压。因此,CYP11B2抑制剂的研究和开发被认为是治疗高血压的一种新方法。在这项研究中,CYP11B2抑制剂的药效团模型被生成,并且最佳模型被用于从中药数据库(TCMD,2009版)中识别潜在的CYP11B2抑制剂。通过分子对接进一步精制该命中,并分析化合物与CYP11B2之间的相互作用。选择具有高Fitvalue,高对接得分和与关键残基的预期相互作用的化合物作为潜在的CYP11B2抑制剂。两种最有前途的化合物,咖啡酸乙酯和亚麻酸,具有较高的Fitvalue和对接分数,被保留用于分子动力学(MD)研究。它们均具有配体结合稳定性,这表明它们可能对CYP11B2具有抑制作用。本研究通过分子模拟方法为高血压治疗提供了新型药物样CYP11B2抑制剂的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号